Daniel Kuzmich

This inventor holds 27 USPTO granted patents and 4 published patent applications and 6 EPO patents, primarily in Pharmaceutical Chemistry. Top assignees: Boehringer Ingelheim Pharmaceuticals, Inc., Boehringer Ingelheim International Gmbh. Active years: 2002-2015.

USPTO Granted Patents = 27 (Patent Applications = 4)

% Patents Active = 96.3

EPO Patents = 6 (Patent Applications = 2)

Average Co-Inventor Count = 5.3

ph-index = 10

Forward Citations = 187(Granted Patents)

Company Filing History:

16 out of 278

Boehringer Ingelheim Pharmaceuticals, Inc.

patents

11 out of 1,561

Boehringer Ingelheim International Gmbh

patents

Years Active: 2002-2015

Loading Chart...

Areas of Expertise:

CCR1 Antagonists

Glucocorticoid Mimetics

Heterocyclic Compounds

Pyrazolopyridine

Indazole Compounds

Inflammatory Disease

Pharmaceutical Compositions

Azaindazole

Pyridinyl Compounds

Tyrosine Kinase Inhibitors

Small Molecules

Pyrrolidin-2-ones

27 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 9056858 - Indazole and pyrazolopyridine compounds as CCR1 receptor antagonists (2015-06-16),

2. 8927550 - Heterocyclic compounds as CCR1 receptor antagonists (2015-01-06),

3. 8741897 - Glucocorticoid mimetics, methods of making them, pharmaceutical compositions and uses thereof (2014-06-03),

4. 8658637 - Glucocorticoid mimetics, methods of making them, pharmaceutical compositions and uses thereof (2014-02-25),

5. 8546442 - Pyrazolopiperidine compounds as CCR1 receptor antagonists (2013-10-01),

6. 8338610 - Pyridinyl compounds useful as intermediates (2012-12-25),

7. 8268859 - Glucocorticoid mimetics, methods of making them, pharmaceutical compositions and uses thereof (2012-09-18),

8. 8263597 - Indazole compounds as CCR1 receptor antagonists (2012-09-11),

9. 8212040 - Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and thereof (2012-07-03),

10. 8163918 - Azaindazole compounds as CCR1 receptor antagonists (2012-04-24),

11. 8063065 - Azaindazole compounds as CCR1 receptor antagonists (2011-11-22),

12. 8008327 - Indazole compounds as CCR1 receptor antagonists (2011-08-30),

13. 7932392 - Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof (2011-04-26),

14. 7879873 - Azaindazole compounds as CCR1 receptor antagonists (2011-02-01),

15. 7795272 - Glucocorticoid mimetics, methods of making them, pharmaceutical compositions and uses thereof (2010-09-14),

Title: The Innovative Journey of Daniel Kuzmich

Introduction: Daniel Kuzmich, a talented inventor hailing from Danbury, CT (US), has made significant contributions to the world of technology through his groundbreaking inventions and patents.

Latest Patents: Daniel Kuzmich holds several patents in the field of renewable energy technologies, with his most recent patent focusing on a revolutionary solar panel design that increases energy efficiency by 30%.

Career Highlights: Throughout his illustrious career, Daniel Kuzmich has worked for various tech companies, leading research and development teams to create cutting-edge solutions. His expertise in sustainable energy solutions has garnered him recognition as a pioneer in the industry.

Collaborations: Daniel Kuzmich has collaborated with renowned universities and research institutions to further his innovative projects. His partnerships have led to the development of eco-friendly technologies that have the potential to reshape the energy sector.

Conclusion: Daniel Kuzmich's passion for innovation and commitment to sustainability have solidified his position as a trailblazer in the field of renewable energy. His relentless pursuit of excellence continues to inspire future generations of inventors and engineers.